The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Testosterone recovery following androgen suppression and prostate radiotherapy (TRANSPORT): Updated individual patient data meta-analyses from the MARCAP consortium.
 
Wee Loon Ong
No Relationships to Disclose
 
Holly Wilhalme
No Relationships to Disclose
 
Jeremy Laurence Millar
Stock and Other Ownership Interests - CSL Limited; Lumos diagnostics; Resmed
 
Allison Steigler
No Relationships to Disclose
 
James William Denham
No Relationships to Disclose
 
David John Joseph
No Relationships to Disclose
 
Soumyajit Roy
No Relationships to Disclose
 
Shawn Malone
Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Knight Pharmaceuticals
Travel, Accommodations, Expenses - Sanofi; Tersera
 
Nicholas George Nickols
Consulting or Advisory Role - Oncolinea Pharmaceuticals
Research Funding - Bayer; Janssen Scientific Affairs; Progenics; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I am listed as inventor on patents related to PyIm polyamides that have been licensed by Gene Sciences
 
Matthew Rettig
Leadership - Aravalent; Survalent
Stock and Other Ownership Interests - Oncovalent Therapeutics; Survalent
Consulting or Advisory Role - Ambrx; Amgen; Clovis Oncology; Inmune Bio; Roivant
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Johnson & Johnson (Inst); Medivation/Astellas (Inst); Novartis (Inst); Progenics
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson
 
Luca Faustino Valle
No Relationships to Disclose
 
Michael L. Steinberg
Honoraria - ViewRay
Consulting or Advisory Role - ViewRay
Research Funding - ViewRay
 
Yilun Sun
No Relationships to Disclose
 
Nicholas George Zaorsky
No Relationships to Disclose
 
Daniel Eidelberg Spratt
Honoraria - Varian Medical Systems
Consulting or Advisory Role - AstraZeneca; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Myovant Sciences; Pfizer; Varian Medical Systems
Research Funding - Janssen (Inst)
 
Luis Souhami
Honoraria - Varian Medical Systems
Consulting or Advisory Role - Abbvie
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Varian Medical Systems
 
Nathalie Carrier
No Relationships to Disclose
 
Abdenour Nabid
Honoraria - Merck
Other Relationship - Québec Urological Association
 
Amar Upadhyaya Kishan
Stock and Other Ownership Interests - ViewRay
Honoraria - Varian Medical Systems; ViewRay; ViewRay
Consulting or Advisory Role - Boston Scientific; Janssen
Research Funding - Janssen Oncology (Inst); Point Biopharma (Inst); ViewRay; ViewRay